We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
-4.54%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$130M
AUM Growth
+$26.6M
(+26%)
Cap. Flow
+$34M
Cap. Flow
% of AUM
26.04%
Top 10 Holdings %
Top 10 Hldgs %
9.96%
Holding
800
New
284
Increased
141
Reduced
77
Closed
294
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sensata Technologies
ST
|
+$1.38M |
| 2 |
Mastercard
MA
|
+$1.33M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.33M |
| 4 |
Abbott
ABT
|
+$1.31M |
| 5 |
Universal Health Services
UHS
|
+$1.29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.17M |
| 2 |
Teradata
TDC
|
+$1.08M |
| 3 |
Phillips 66
PSX
|
+$1.05M |
| 4 |
Marathon Petroleum
MPC
|
+$1.05M |
| 5 |
Pentair
PNR
|
+$1.05M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.22% |
| 2 | Financials | 13.03% |
| 3 | Industrials | 12.41% |
| 4 | Technology | 11.95% |
| 5 | Healthcare | 10.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
ING
ING
$92.9B
| $82.3K | 0.06% |
+5,800
| New | +$80K |
|
352
CEMIG Preferred Shares
CIG
$6.06B
| $82.2K | 0.06% |
+25,894
| New | +$106K |
|
|
SRCL
353
DELISTED
Stericycle Inc
SRCL
| $81.6K | 0.06% |
700
-1,100
| -61% | -$130K |
|
354
Bank of Montreal
BMO
$123B
| $81K | 0.06% |
+1,100
| New | +$82.7K |
|
355
Timken Company
TKR
$9.19B
| $80.5K | 0.06% |
+1,900
| New | +$87.4K |
|
356
Reinsurance Group of America
RGA
$15.5B
| $80.1K | 0.06% |
+1,000
| New | +$81.4K |
|
357
Jones Lang LaSalle
JLL
$15.8B
| $75.8K | 0.06% |
+600
| New | +$78.1K |
|
358
XPO
XPO
$23.4B
| $75.3K | 0.06% |
+5,783
| New | +$63.1K |
|
359
Snap-on
SNA
$21.5B
| $72.6K | 0.06% |
600
-1,500
| -71% | -$184K |
|
360
IQVIA
IQV
$40.7B
| $72.5K | 0.06% |
1,300
+900
| +225% | +$50.3K |
|
361
Amgen
AMGN
$209B
| $70.2K | 0.05% |
500
-1,600
| -76% | -$209K |
|
362
Henry Schein
HSIC
$9.78B
| $69.9K | 0.05% |
+1,530
| New | +$70.9K |
|
363
ICICI Bank
IBN
$107B
| $69.7K | 0.05% |
+7,810
| New | +$73K |
|
|
TLM.PRB
364
DELISTED
TALISMAN ENGY 8.90% PRF6/15/48
TLM.PRB
| $68.9K | 0.05% |
+7,970
| New | +$68.9K |
|
365
Ciena
CIEN
$46.8B
| $68.4K | 0.05% |
+4,093
| New | +$80.2K |
|
366
Franco-Nevada
FNV
$41.3B
| $68.4K | 0.05% |
+1,400
| New | +$77.9K |
|
367
PNC Financial Services
PNC
$99.1B
| $68.1K | 0.05% |
796
+789
| +11,271% | +$67.1K |
|
|
TWX
368
DELISTED
Time Warner Inc
TWX
| $67.7K | 0.05% |
+900
| New | +$69.7K |
|
369
Valmont Industries
VMI
$8.81B
| $67.5K | 0.05% |
500
+200
| +67% | +$28.7K |
|
370
Cummins
CMI
$83.6B
| $66K | 0.05% |
500
-400
| -44% | -$57.7K |
|
371
Fortinet
FTNT
$112B
| $65.6K | 0.05% |
+12,990
| New | +$65.6K |
|
372
Franklin Resources
BEN
$16.8B
| $65.5K | 0.05% |
1,200
+400
| +50% | +$22.4K |
|
|
HOLX
373
DELISTED
Hologic
HOLX
| $65.4K | 0.05% |
+2,689
| New | +$67.9K |
|
374
CarMax
KMX
$8.39B
| $64.9K | 0.05% |
1,397
-1,103
| -44% | -$56.5K |
|
375
Assurant
AIZ
$13.9B
| $64.3K | 0.05% |
1,000
+400
| +67% | +$26.2K |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q3 2014 Portfolio in Review
As of Q3 2014, Seven Eight Capital held 800 positions worth $130M, up 26% from $104M the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Seven Eight Capital deployed $34M of net new capital in Q3 2014, opening 284 new positions and adding to 141 existing holdings. Its largest new stake was Sensata Technologies: 29,200 shares worth $1.3M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 13% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Teradata, an estimated $1.08M trimmed.
- Seven Eight Capital's largest Q3 2014 buy was Sensata Technologies: 29,200 shares worth $1.3M.
- Seven Eight Capital added most to Medtronic in Q3 2014, an estimated $1.27M increase.
- Seven Eight Capital's biggest Q3 2014 reduction was Teradata, cutting an estimated $1.08M.
- Seven Eight Capital fully exited Allergan plc in Q3 2014, selling an estimated $1.17M.
- Seven Eight Capital's ten largest holdings make up 10% of its $130M portfolio in Q3 2014.
- Seven Eight Capital opened 284 new positions and closed 294 in Q3 2014.
- Seven Eight Capital's portfolio value rose 26% quarter-over-quarter to $130M.
Based on Seven Eight Capital's 13F filing for Q3 2014, filed 13 Nov 2014.